Fact boxes that inform individual decisions may contribute to a more positive evaluation of COVID-19 vaccinations at the population level

Felix G Rebitschek, Christin Ellermann, Mirjam A Jenny, Nico A Siegel, Christian Spinner, Gert G Wagner, Felix G Rebitschek, Christin Ellermann, Mirjam A Jenny, Nico A Siegel, Christian Spinner, Gert G Wagner

Abstract

Objective: For an effective control of the SARS-CoV-2 pandemic with vaccines, most people in a population need to be vaccinated. It is thus important to know how to inform the public with reference to individual preferences-while also acknowledging the societal preference to encourage vaccinations. According to the health care standard of informed decision-making, a comparison of the benefits and harms of (not) having the vaccination would be required to inform undecided and skeptical people. To test evidence-based fact boxes, an established risk communication format, and to inform their development, we investigated their contribution to knowledge and evaluations of COVID-19 vaccines.

Methods: We conducted four studies (1, 2, and 4 were population-wide surveys with N = 1,942 to N = 6,056): Study 1 assessed the relationship between vaccination knowledge and intentions in Germany over three months. Study 2 assessed respective information gaps and needs of the population in Germany. In parallel, an experiment (Study 3) with a mixed design (presentation formats; pre-post-comparison) assessed the effect of fact boxes on risk perceptions and fear, using a convenience sample (N = 719). Study 4 examined how effective two fact box formats are for informing vaccination intentions, with a mixed experimental design: between-subjects (presentation formats) and within-subjects (pre-post-comparison).

Results: Study 1 showed that vaccination knowledge and vaccination intentions increased between November 2020 and February 2021. Study 2 revealed objective information requirements and subjective information needs. Study 3 showed that the fact box format is effective in adjusting risk perceptions concerning COVID-19. Based on those results, fact boxes were revised and implemented with the help of a national health authority in Germany. Study 4 showed that simple fact boxes increase vaccination knowledge and positive evaluations in skeptics and undecideds.

Conclusion: Fact boxes can inform COVID-19 vaccination intentions of undecided and skeptical people without threatening societal vaccination goals of the population.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Proportion of respondents according to…
Fig 1. Proportion of respondents according to their intention to get vaccinated against COVID-19 or indicating that they already had.
Independent samples were weighted at the time of their assessment. Error bars show 95% confidence intervals.
Fig 2. Number of correct items increased…
Fig 2. Number of correct items increased over two months according to respondents’ intention to get vaccinated against COVID-19.
The independent samples were weighted at the time of their assessment. Error bars show the standard error of the mean.
Fig 3. English translation of the simple…
Fig 3. English translation of the simple fact box for people between the ages of 18 and 60 from Study 4.
Fig 4
Fig 4
Proportion of correct responses to five knowledge items according to different levels of education and household net income for respondents younger than 60 years of age (A) and 60 years of age and older (B). The sample is weighted. Error bars show the standard error of the mean.

References

    1. Bartsch SM, O’Shea KJ, Ferguson MC, Bottazzi ME, Wedlock PT, Strych U, et al.. Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention. American Journal of Preventive Medicine. 2020;59(4):493–503. doi: 10.1016/j.amepre.2020.06.011
    1. Haug S, Schnell R, Weber K. Impfbereitschaft mit einem COVID-19-Vakzin und Einflussfaktoren. Ergebnisse einer telefonischen Bevölkerungsbefragung. Das Gesundheitswesen. 2021;83(10):789–96.
    1. Robert Koch Institute. COVID-19 Impfquoten-Monitoring in Deutschland (COVIMO) -1. Report. 2021.
    1. Bundesministerium für Gesundheit. Impfdashboard 2022 [5 August 2022]. Available from: .
    1. Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, et al.. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. The European Journal of Health Economics. 2020;21(7):977–82. doi: 10.1007/s10198-020-01208-6
    1. Wissenschaft im Dialog. Wissenschaftsbarometer 2020—Report. 2020.
    1. Quinn SC, Kumar S, Freimuth VS, Kidwell K, Musa D. Public willingness to take a vaccine or drug under Emergency Use Authorization during the 2009 H1N1 pandemic. Biosecurity and Bioterrorism: Biodefense strategy, Practice, and Science. 2009;7(3):275–90. doi: 10.1089/bsp.2009.0041
    1. Betsch C, Korn L, Felgendreff L, Eitze S, Schmid P, Sprengholz P, et al.. German COVID-19 Snapshot Monitoring (COSMO)-Welle 15 (23.06.2020). PrePrint. 2020.
    1. Thießen M. Immunity as Relativity: German Vaccination Campaigns and Debates in Times of COVID-19. Historical Social Research/Historische Sozialforschung. 2021;46(4):316–38.
    1. Schoch-Spana M, Brunson E, Chandler H, Gronvall GK, Ravi S, Sell TK, et al.. Recommendations on how to manage anticipated communication dilemmas involving medical countermeasures in an emergency. Public Health Reports. 2018;133(4):366–78. doi: 10.1177/0033354918773069
    1. Blastland M, Freeman AL, van der Linden S, Marteau TM, Spiegelhalter D. Five rules for evidence communication. Nature. 2020;587(7834):362–4. doi: 10.1038/d41586-020-03189-1
    1. Braddock CH III, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999;282(24):2313–20. doi: 10.1001/jama.282.24.2313
    1. Bundesministerium für Gesundheit. Gesetz zur Verbesserung der Rechte von Patientinnen und Patienten. Bundesanzeiger Verlag, 2013.
    1. Kerridge I, Lowe M, Henry D. Ethics and evidence based medicine. BMJ. 1998;316(7138):1151–3. doi: 10.1136/bmj.316.7138.1151
    1. Elmore JG, Ganschow PS, Geller BM. Communication between patients and providers and informed decision making. Journal of the National Cancer Institute Monographs. 2010;2010(41):204–9. doi: 10.1093/jncimonographs/lgq038
    1. Eddy DM. Comparing benefits and harms: the balance sheet. JAMA 1990;263(18):2493–505. doi: 10.1001/jama.263.18.2493
    1. Schwartz LM, Woloshin S, Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Annals of Internal Medicine. 2009;150(8):516–27. doi: 10.7326/0003-4819-150-8-200904210-00106
    1. McDowell M, Rebitschek FG, Gigerenzer G, Wegwarth O. A simple tool for communicating the benefits and harms of health interventions. MDM Policy & Practice. 2016;1(1):2381468316665365.
    1. AOK-Bundesverband, Harding Center for Risk Literacy. AOK-Faktenboxen 2016. [8 August 2022]. Available from: .
    1. Harding Center for Risk Literacy. Fact Boxes 2021. [8 August 2022]. Available from: .
    1. Hertwig R, Grüne-Yanoff T. Nudging and boosting: Steering or empowering good decisions. Perspectives on Psychological Science. 2017;12(6):973–86. doi: 10.1177/1745691617702496
    1. Eber MR, Sunstein CR, Hammitt JK, Yeh JM. The modest effects of fact boxes on cancer screening. Journal of Risk and Uncertainty. 2021;62(1):29–54. doi: 10.1007/s11166-021-09344-x
    1. McDowell M, Gigerenzer G, Wegwarth O, Rebitschek FG. Effect of tabular and icon fact box formats on comprehension of benefits and harms of prostate cancer screening: A randomized trial. Medical Decision Making. 2019;39(1):41–56. doi: 10.1177/0272989X18818166
    1. Brick C, McDowell M, Freeman AL. Risk communication in tables versus text: a registered report randomized trial on ‘fact boxes’. Royal Society Open Science. 2020;7(3):190876. doi: 10.1098/rsos.190876
    1. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, et al.. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Medical Informatics and Decision Making. 2013;13(2):1–15. doi: 10.1186/1472-6947-13-S2-S7
    1. Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PloS ONE. 2018;13(12):e0208601. doi: 10.1371/journal.pone.0208601
    1. Zheng H, Jiang S, Wu Q. Factors influencing COVID-19 vaccination intention: The roles of vaccine knowledge, vaccine risk perception, and doctor-patient communication. Patient Education and Counseling. 2022;105(2):277–83. doi: 10.1016/j.pec.2021.09.023
    1. Wegwarth O, Kurzenhäuser-Carstens S, Gigerenzer G. Overcoming the knowledge–behavior gap: The effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision. Vaccine. 2014;32(12):1388–93. doi: 10.1016/j.vaccine.2013.12.038
    1. Deutsche Gesellschaft für Psychologie. Ethisches Handeln in der psychologischen Forschung. Empfehlungen der Deutschen Gesellschaft für Psychologie für Forschende und Ethikkommissionen. Göttingen (Germany): Hogrefe Verlag; 2018.
    1. Siegel N, Wagner GG. infratest: Corona Online Meinungs Panel Survey Spezial (COMPASS) 2021. [8 August 2022]. Available from: .
    1. Wegwarth O, Wagner GG, Spies C, Hertwig R. Assessment of German public attitudes toward health communications with varying degrees of scientific uncertainty regarding COVID-19. JAMA network open. 2020;3(12):e2032335–e. doi: 10.1001/jamanetworkopen.2020.32335
    1. STIKO. Beschluss der STIKO zur 2. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung. Epidemiologisches Bulletin. 2021;5.
    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655
    1. Bunge M, Mühlhauser I, Steckelberg A. What constitutes evidence-based patient information? Overview of discussed criteria. Patient Education and Counseling. 2010;78(3):316–28. doi: 10.1016/j.pec.2009.10.029
    1. Lühnen J, Albrecht M, Hanßen K, Hildebrandt J, Steckelberg A. Leitlinie evidenzbasierte Gesundheitsinformation: Einblick in die Methodik der Entwicklung und Implementierung. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen. 2015;109(2):159–65. doi: 10.1016/j.zefq.2015.03.004
    1. Kerr JR, Schneider CR, Recchia G, Dryhurst S, Sahlin U, Dufouil C, et al.. Correlates of intended COVID-19 vaccine acceptance across time and countries: results from a series of cross-sectional surveys. BMJ Open. 2021;11(8):e048025. doi: 10.1136/bmjopen-2020-048025
    1. Ling M, Kothe EJ, Mullan BA. Predicting intention to receive a seasonal influenza vaccination using Protection Motivation Theory. Social Science & Medicine. 2019;233:87–92. doi: 10.1016/j.socscimed.2019.06.002
    1. Mesch GS, Schwirian KP. Social and political determinants of vaccine hesitancy: Lessons learned from the H1N1 pandemic of 2009–2010. American Journal of Infection Control. 2015;43(11):1161–5. doi: 10.1016/j.ajic.2015.06.031
    1. Helios Kliniken. Corona versus Grippe: Der Unterschied liegt im Detail [15 December 2020]. Available from: .
    1. Zikmund-Fisher BJ, Fagerlin A, Ubel PA. Risky feelings: why a 6% risk of cancer does not always feel like 6%. Patient Education and Counseling. 2010;81:87–93.
    1. Palm R, Bolsen T, Kingsland JT. The effect of frames on COVID-19 vaccine resistance. Frontiers in Political Science. 2021;3(41):661257.
    1. Frewer LJ, Miles S, Brennan M, Kuznesof S, Ness M, Ritson C. Public preferences for informed choice under conditions of risk uncertainty. Public Understanding of Science. 2002;11(4):363–72.
    1. Renn O, Levine D. Credibility and trust in risk communication. In: Kasperson RE, Stallen PJM, editors. Communicating Risks to the Public: International Perspectives. Dordrecht (Netherlands): Springer; 1991. p. 175–217.
    1. Kerr JR, Freeman AL, Marteau TM, van der Linden S. Effect of information about COVID-19 vaccine effectiveness and side effects on behavioural intentions: two online experiments. Vaccines. 2021;9(4):379. doi: 10.3390/vaccines9040379
    1. Lawes-Wickwar S, Ghio D, Tang MY, Keyworth C, Stanescu S, Westbrook J, et al.. A rapid systematic review of public responses to health messages encouraging vaccination against infectious diseases in a pandemic or epidemic. Vaccines. 2021;9(2):72. doi: 10.3390/vaccines9020072
    1. Akl EA, Oxman AD, Herrin J, Vist GE, Terrenato I, Sperati F, et al.. Using alternative statistical formats for presenting risks and risk reductions. The Cochrane Database of Systematic Reviews. 2011;(3):CD006776. doi: 10.1002/14651858.CD006776.pub2
    1. Durand M-A, Carpenter L, Dolan H, Bravo P, Mann M, Bunn F, et al.. Do interventions designed to support shared decision-making reduce health inequalities? A systematic review and meta-analysis. PloS ONE. 2014;9(4):e94670. doi: 10.1371/journal.pone.0094670
    1. Enard KR, Dolan Mullen P, Kamath GR, Dixon NM, Volk RJ. Are cancer-related decision aids appropriate for socially disadvantaged patients? A systematic review of US randomized controlled trials. BMC Medical Informatics and Decision Making. 2016;16(1):1–15. doi: 10.1186/s12911-016-0303-6
    1. Lorenc T, Petticrew M, Welch V, Tugwell P. What types of interventions generate inequalities? Evidence from systematic reviews. J Epidemiol Community Health. 2013;67(2):190–3. doi: 10.1136/jech-2012-201257
    1. Lipkus IM, Peters E, Kimmick G, Liotcheva V, Marcom P. Breast cancer patients’ treatment expectations after exposure to the decision aid program adjuvant online: the influence of numeracy. Medical Decision Making. 2010;30(4):464–73. doi: 10.1177/0272989X09360371
    1. O’Neill J, Tabish H, Welch V, Petticrew M, Pottie K, Clarke M, et al.. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. Journal of Clinical Epidemiology. 2014;67(1):56–64. doi: 10.1016/j.jclinepi.2013.08.005
    1. Harding Center for Risk Literacy, Robert Koch Institute. Faktenboxen zur mRNA-Schutzimpfung gegen COVID-19. 2021.
    1. Korn L, Böhm R, Meier NW, Betsch C. Vaccination as a social contract. Proceedings of the National Academy of Sciences. 2020;117(26):14890–9. doi: 10.1073/pnas.1919666117

Source: PubMed

3
Abonneren